United Therapeutics (UTHR)

United Therapeutics Financial Statements

United Therapeutics Financial Overview

United Therapeutics's market cap is currently ―. The company's EPS TTM is $14.44; its P/E ratio is 16.50; United Therapeutics is scheduled to report earnings on August 3, 2022, and the estimated EPS forecast is $4.42. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 461.90M$ 415.20M$ 444.70M$ 446.50M$ 379.10M
Gross Profit$ 436.00M$ 380.60M$ 417.00M$ 409.30M$ 356.10M
EBIT$ 313.40M$ 145.20M$ 209.00M$ 221.20M$ 37.10M
EBITDA$ 325.90M$ 157.80M$ 221.40M$ 233.60M$ 49.60M
Net Income Common Stockholders$ 239.90M$ 112.20M$ 162.70M$ 172.60M$ 28.30M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 1.58B$ 1.73B$ 1.83B$ 1.93B$ 1.97B
Total Assets$ 5.36B$ 5.17B$ 5.05B$ 4.84B$ 4.64B
Total Debt$ 800.00M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -780.50M$ -1.73B$ -1.83B$ -1.93B$ -1.97B
Total Liabilities$ 1.18B$ 1.21B$ 1.22B$ 1.21B$ 1.20B
Stockholders Equity$ 3.28B$ 3.40B$ 3.45B$ 3.64B$ 3.83B
Cash Flow
Free Cash Flow$ 275.20M$ 104.00M$ 162.30M$ 131.90M$ 79.20M
Operating Cash Flow$ 288.70M$ 174.60M$ 185.60M$ 148.20M$ 89.80M
Investing Cash Flow$ -359.20M$ -195.80M$ -235.90M$ -48.90M$ -6.30M
Financing Cash Flow$ -11.00M$ 7.50M$ 16.60M$ 10.60M$ 10.10M
Currency in USD

United Therapeutics Earnings and Revenue History

United Therapeutics Debt to Assets

United Therapeutics Cash Flow

United Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis